Naloxone Autoinjectors ACAN
Solicitation number W6369-27-A041
Publication date
Closing date and time 2026/09/02 14:00 EDT
Description
The Department of National Defence (DND) through the Strategic Medical Countermeasures Program (SMCP), on behalf of the Canadian Forces Health Services Group (CF H Svcs Gp), has a requirement for the supply of 3,600 of 10 mg Naloxone Auto-injectors (AIs) and 200 trainers to provide emergency treatment and/or prophylaxis of respiratory depression where the use of high-potency opioids is confirmed or suspected, and an associated re-usable training device to train users on the safe handling and use of the device.
The Naloxone Auto-Injectors must provide emergency treatment and/or prophylaxis of respiratory depression where the use of high-potency opioids is confirmed or suspected. The product must consist of a 10 mg naloxone hydrochloride auto-injector designed for self-aid and buddy-aid applications in operational environments and capable of administration through clothing and personal protective equipment. The requirement also includes reusable training devices to support user training on the safe handling and administration of the auto-injector.
The initial requirement consists of the supply of 3,600 Naloxone Auto-Injectors (10 mg) and 200 reusable training devices. The resulting contract is anticipated to be valid from contract award date to 31 March 2029, with two (2) additional one-year option periods extending to 31 March 2031.
This procurement will be conducted through an Advance Contract Award Notice (ACAN). The Government of Canada has identified Kaléo, Inc. as the only supplier currently known to satisfy the operational, clinical and technical requirements associated with this requirement. Suppliers that consider themselves fully qualified and capable of meeting the complete requirement may submit a Statement of Capabilities during the posting period.
The Crown retains the rights to negotiate with suppliers on any procurement.
Documents may be submitted in either official language of Canada.
Barring any applicable trade agreement exceptions or other legal restrictions, eligible suppliers may participate in this solicitation process.
NOTE TO SUPPLIERS:
Procurement Assistance Canada offers seminars to businesses interested in learning how to sell goods and services to the Government of Canada. These seminars are provided free of charge.
Contract duration
The estimated contract period will be 28 month(s), with a proposed start date of 2026/11/20.
Trade agreements
-
North American Free Trade Agreement (NAFTA)
-
World Trade Organization Agreement on Government Procurement (WTO GPA)
-
Canada-Chile Free Trade Agreement (CCFTA)
-
Canada-Peru Free Trade Agreement (CPFTA)
-
Canada-Colombia Free Trade Agreement
-
Canada-Panama Free Trade Agreement
-
Canada-Honduras Free Trade Agreement
-
Canada-Korea Free Trade Agreement (CKFTA)
-
Canadian Free Trade Agreement (CFTA)
-
Canada-European Union Comprehensive Economic and Trade Agreement (CETA)
-
Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP)
-
Canada-Ukraine Free Trade Agreement (CUFTA)
-
Canada-UK Trade Continuity Agreement (Canada-UK TCA)
Reason for limited tendering
A contracting officer can use limited tendering for specific reasons outlined in the applicable trade agreements. The reason for this contract is described below:
-
Exclusive Rights
Contact information
Contracting organization
- Organization
-
Department of National Defence (DND)
- Address
-
101 Colonel By Drive
Ottawa, ON, K1A 0K2Canada
- Contracting authority
- Luis Eduardo Vides Lozano
- Phone
- (873) 469-7365
- Email
- luiseduardo.videslozano@forces.gc.ca
- Address
-
105 Hotel de Ville
Gatineau, QC, J8X 4H7Canada
Bidding details
| Document title | Amendment no. | Language | Unique downloads | Date added |
|---|---|---|---|---|
| W6369-27-A041- Naloxone Autoinjectors_ACAN_EN.pdf | 001 | EN | 11 | 2026/08/18 |
| W6369-27-A041- Naloxone Auto-Injecteur de Naloxone_PAC_FR_Final.pdf | 001 | FR | 4 | 2026/08/18 |